article

1. Deprescribing of Antihypertensive Medications and Cognitive Function in Nursing Home Residents..  JAMA internal medicine.  184:1347-1355. 2024
2. Cognitive Trajectories in Older Adults Diagnosed With Hematologic Malignant Neoplasms..  JAMA network open.  7:-. 2024
3. High-risk medication use among older adults with cognitive impairment living alone in the United States..  Journal of the American Geriatrics Society.  2024
4. Top 10 Signs and Symptoms of Psychotropic Adverse Drug Events to Monitor in Residents of Long-Term Care Facilities..  Journal of the American Medical Directors Association.  25:-. 2024
5. Complex Patterns of Antihypertensive Treatment Changes in Long-Term Care Residents..  Journal of the American Medical Directors Association.  25:-. 2024
6. eConsultation for Deprescribing Among Older Adults: Clinician Perspectives on Implementation Barriers and Facilitators..  Journal of general internal medicine.  39:2461-2470. 2024
7. Antihypertensive Medication and Fracture Risk in Older Veterans Health Administration Nursing Home Residents..  JAMA internal medicine.  184:661-669. 2024
8. Cognitive, physical, and sensory deficits that can affect everyday medication use among older adults: A national view..  Journal of the American Geriatrics Society.  72:2254-2257. 2024
9. Association of Race and Ethnicity With Postoperative Gabapentinoid and Opioid Prescribing Trends for Older Adults..  The Journal of surgical research.  47-52. 2024
10. Which older adults are at highest risk of prescribing cascades? A national study of the gabapentinoid-loop diuretic cascade..  Journal of the American Geriatrics Society.  72:1728-1740. 2024
11. The U.S. deprescribing research network: Catalyzing research and action to optimize medication use in older adults..  Journal of the American Geriatrics Society.  72:1611-1613. 2024
12. Clinical Outcomes of Intensive Inpatient Blood Pressure Management in Hospitalized Older Adults..  JAMA internal medicine.  183:715-723. 2023
13. Medication misuse and overuse in community-dwelling persons with dementia..  Journal of the American Geriatrics Society.  71:3086-3098. 2023
14. Trends in the Use of Gabapentinoids and Opioids in the Postoperative Period Among Older Adults..  JAMA network open.  6:-. 2023
15. Ten deprescribing articles you should know about: A guide for newcomers to the field..  Basic & clinical pharmacology & toxicology.  133:661-664. 2023
16. The state of deprescribing research: How did we get here?.  Basic & clinical pharmacology & toxicology.  133:657-660. 2023
17. Physician Perspectives on the Use of Beta Blockers in Heart Failure With Preserved Ejection Fraction..  The American journal of cardiology.  70-74. 2023
18. Systolic blood pressure, antihypertensive treatment, and cardiovascular and mortality risk in VA nursing home residents..  Journal of the American Geriatrics Society.  71:2131-2140. 2023
19. Safety implications of concomitant administration of antidepressants and opioid analgesics in surgical patients..  Expert opinion on drug safety.  22:477-484. 2023
20. Value assessment of deprescribing interventions: Suggestions for improvement..  Journal of the American Geriatrics Society.  71:2023-2027. 2023
21. Implications of Under-Reporting Medication Side Effects: Beta-Blockers in Heart Failure as a Case Example..  Drugs & aging.  40:285-291. 2023
22. History of Incarceration and Its Association With Geriatric and Chronic Health Outcomes in Older Adulthood..  JAMA network open.  6:-. 2023
23. New psychotropic medication use among Medicare beneficiaries with dementia after hospital discharge..  Journal of the American Geriatrics Society.  71:1134-1144. 2022
24. Can markers of disease severity improve the predictive power of claims-based multimorbidity indices?.  Journal of the American Geriatrics Society.  71:845-857. 2022
25. Development and validation of novel multimorbidity indices for older adults..  Journal of the American Geriatrics Society.  71:121-135. 2022
26. Prevalence of Potentially Inappropriate Medication Prescribing in US Nursing Homes, 2013-2017..  Journal of general internal medicine.  38:1563-1566. 2022
27. Changes in the Hierarchy of Functional Impairment From Middle Age to Older Age..  The journals of gerontology. Series A, Biological sciences and medical sciences.  77:1577-1584. 2022
28. N-of-1 trials to facilitate evidence-based deprescribing: Rationale and case study..  British journal of clinical pharmacology.  88:4460-4473. 2022
29. Recommendations for outcome measurement for deprescribing intervention studies..  Journal of the American Geriatrics Society.  70:2487-2497. 2022
30. Trends in blood pressure diagnosis, treatment, and control among VA nursing home residents, 2007-2018..  Journal of the American Geriatrics Society.  70:2280-2290. 2022
31. Moving Deprescribing Upstream..  Journal of general internal medicine.  37:3176-3177. 2022
32. Glycemic treatment deintensification practices in nursing home residents with type 2 diabetes..  Journal of the American Geriatrics Society.  70:2019-2028. 2022
33. Attitudes toward deprescribing among older adults with dementia in the United States..  Journal of the American Geriatrics Society.  70:1764-1773. 2022
34. Exploring the Dynamics of Week-to-Week Blood Pressure in Nursing Home Residents Before Death..  American journal of hypertension.  35:65-72. 2022
35. Association of Antihypertensives and Cognitive Impairment in Long-Term Care Residents..  Journal of Alzheimer's disease : JAD.  86:1149-1158. 2022
36. Association of Social Support With Functional Outcomes in Older Adults Who Live Alone..  JAMA internal medicine.  182:26-32. 2022
37. Perceptions of Older Men Using a Mobile Health App to Monitor Lower Urinary Tract Symptoms and Tamsulosin Side Effects: Mixed Methods Study..  JMIR human factors.  8:-. 2021
38. Use of High-risk Medications Among Lonely Older Adults: Results From a Nationally Representative Sample..  JAMA internal medicine.  181:1528-1530. 2021
39. Intensification of Diabetes Medications at Hospital Discharge and Clinical Outcomes in Older Adults in the Veterans Administration Health System..  JAMA network open.  4:-. 2021
40. Deprescribing and deimplementation: Time for transformative change..  Journal of the American Geriatrics Society.  69:3693-3695. 2021
41. Deprescribing Blood Pressure Treatment in Long-Term Care Residents..  Journal of the American Medical Directors Association.  22:2540-2546.e2. 2021
42. Unplanned hospital visits after ambulatory surgical care..  PloS one.  16:-. 2021
43. Polypharmacy among older adults with dementia compared with those without dementia in the United States..  Journal of the American Geriatrics Society.  69:2464-2475. 2021
44. Adverse Drug Events After Hospitalization-Are We Missing the Mark?.  JAMA internal medicine.  181:618-619. 2021
45. High incidence of fractures after R-CHOP-like chemotherapy for aggressive B-cell non-Hodgkin lymphomas..  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer.  29:5399-5408. 2021
46. Long-term individual and population functional outcomes in older adults with atrial fibrillation..  Journal of the American Geriatrics Society.  69:1570-1578. 2021
47. Systematic Review and Meta-Analysis of the Association Between Non-Steroidal Anti-Inflammatory Drugs and Operative Bleeding in the Perioperative Period..  Journal of the American College of Surgeons.  232:765-790.e1. 2021
48. Older Adults' Persistence to Antihypertensives Prescribed at Hospital Discharge: a Retrospective Cohort Study..  Journal of general internal medicine.  36:3900-3902. 2021
49. Long-term individual and population functional outcomes in older adults with atrial fibrillation..  medRxiv : the preprint server for health sciences.  2020
50. Long-term individual and population functional outcomes in older adults with atrial fibrillation..  medRxiv : the preprint server for health sciences.  2020
51. Succeeding in Aging Research During the Pandemic: Strategies for Fellows and Junior Faculty..  Journal of the American Geriatrics Society.  69:8-11. 2020
52. Comparative Effectiveness of Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors in Older Nursing Home Residents After Myocardial Infarction: A Retrospective Cohort Study..  Drugs & aging.  37:755-766. 2020
53. Effect of a patient activation intervention on hypertension medication optimization: results from a randomized clinical trial..  The American journal of managed care.  26:382-387. 2020
54. Improving the American Diabetes Association Framework for individualizing treatment in older adults: evaluating life expectancy..  BMJ open diabetes research & care.  8. 2020
55. Optimizing Medication Management During the COVID-19 Pandemic: An Implementation Guide for Post-Acute and Long-Term Care..  Journal of the American Geriatrics Society.  68:1362-1365. 2020
56. Meeting the Care Needs of Older Adults Isolated at Home During the COVID-19 Pandemic..  JAMA internal medicine.  180:819-820. 2020
57. Antihypertensive Prescribing Cascades as High-Priority Targets for Deprescribing..  JAMA internal medicine.  180:651-652. 2020
58. Effects of Statins for Secondary Prevention on Functioning and Other Outcomes Among Nursing Home Residents..  Journal of the American Medical Directors Association.  21:500-507.e8. 2020
59. Prevalence of Diabetes Medication Intensifications in Older Adults Discharged From US Veterans Health Administration Hospitals..  JAMA network open.  3:-. 2020
60. A systems approach to identifying the challenges of implementing deprescribing in older adults across different health-care settings and countries: a narrative review..  Expert review of clinical pharmacology.  13:233-245. 2020
61. Clinical Outcomes After Intensifying Antihypertensive Medication Regimens Among Older Adults at Hospital Discharge..  JAMA internal medicine.  179:1528-1536. 2019
62. What Is a Medication-Related Problem? A Qualitative Study of Older Adults and Primary Care Clinicians..  Journal of general internal medicine.  35:724-731. 2019
63. Physician Perspectives on Deprescribing Cardiovascular Medications for Older Adults..  Journal of the American Geriatrics Society.  68:78-86. 2019
64. Functional Status as Measured by Geriatric Assessment Predicts Inferior Survival in Older Allogeneic Hematopoietic Cell Transplantation Recipients..  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.  26:189-196. 2019
65. Often Off-label: Questionable Gabapentinoid Use Noted at Hospital Admission Warrants Deprescribing..  Journal of hospital medicine.  14:579-580. 2019
66. Patient-Important Adverse Events of β-blockers in Frail Older Adults after Acute Myocardial Infarction..  The journals of gerontology. Series A, Biological sciences and medical sciences.  74:1277-1281. 2019
67. Deprescribing in Older Adults With Cardiovascular Disease..  Journal of the American College of Cardiology.  73:2584-2595. 2019
68. Association of Functional Impairment in Middle Age With Hospitalization, Nursing Home Admission, and Death..  JAMA internal medicine.  179:668-675. 2019
69. Association Between Secondary Prevention Medication Use and Outcomes in Frail Older Adults After Acute Myocardial Infarction..  Circulation. Cardiovascular quality and outcomes.  12:-. 2019
70. A systematic review of methods for determining cross-sectional active medications using pharmacy databases..  Pharmacoepidemiology and drug safety.  28:403-421. 2019
71. Muscle Relaxant Use Among Hemodialysis Patients: Prevalence, Clinical Indications, and Adverse Outcomes..  American journal of kidney diseases : the official journal of the National Kidney Foundation.  73:525-532. 2019
72. Psychoactive Medications and Adverse Outcomes among Older Adults Receiving Hemodialysis..  Journal of the American Geriatrics Society.  67:449-454. 2019
73. Making Function Part of the Conversation: Clinician Perspectives on Measuring Functional Status in Primary Care..  Journal of the American Geriatrics Society.  67:493-502. 2018
74. Reducing hospital admissions for adverse drug events through coordinated pharmacist care: learning from Hawai'i without a field trip..  BMJ quality & safety.  28:91-93. 2018
75. Overcoming Inertia to Improve Medication Use and Deprescribing..  JAMA.  320:1867-1869. 2018
76. Deprescribing: Future directions for research..  Research in social & administrative pharmacy : RSAP.  15:801-805. 2018
77. Intensification of older adults' outpatient blood pressure treatment at hospital discharge: national retrospective cohort study..  BMJ (Clinical research ed.).  -. 2018
78. Impact of a nurse-based intervention on medication outcomes in vulnerable older adults..  BMC geriatrics.  18:-. 2018
79. Characteristics Associated With Physical Function Trajectories in Older Adults With Cancer During Chemotherapy..  Journal of pain and symptom management.  56:678-688.e1. 2018
80. Outcomes of "diabetes-friendly" vs "diabetes-unfriendly" β-blockers in older nursing home residents with diabetes after acute myocardial infarction..  Diabetes, obesity & metabolism.  20:2724-2732. 2018
81. Gabapentin and Pregabalin Use and Association with Adverse Outcomes among Hemodialysis Patients..  Journal of the American Society of Nephrology : JASN.  29:1970-1978. 2018
82. Medication burden attributable to chronic co-morbid conditions in the very old and vulnerable..  PloS one.  13:-. 2018
83. Opioid Analgesics and Adverse Outcomes among Hemodialysis Patients..  Clinical journal of the American Society of Nephrology : CJASN.  13:746-753. 2018
84. Developing a Core Outcome Set for Trials to Improve Medication Use: Guidelines or Guidance?.  Journal of the American Geriatrics Society.  66:1058-1059. 2018
85. Functional Impairment and Decline in Middle Age: A Cohort Study..  Annals of internal medicine.  167:761-768. 2017
86. Secondary Prevention Medication Use After Myocardial Infarction in U.S. Nursing Home Residents..  Journal of the American Geriatrics Society.  65:2397-2404. 2017
87. Current approaches to measuring functional status among older adults in VA primary care clinics..  Federal practitioner : for the health care professionals of the VA, DoD, and PHS.  34:26-31. 2017
88. Distinct Physical Function Profiles in Older Adults Receiving Cancer Chemotherapy..  Journal of pain and symptom management.  54:263-272. 2017
89. Bringing functional status into a big data world: Validation of national Veterans Affairs functional status data..  PloS one.  12:-. 2017
90. Association of β-Blockers With Functional Outcomes, Death, and Rehospitalization in Older Nursing Home Residents After Acute Myocardial Infarction..  JAMA internal medicine.  177:254-262. 2017
91. Folic Acid Supplementation Is Suboptimal in a National Cohort of Older Veterans Receiving Low Dose Oral Methotrexate..  PloS one.  11:-. 2016
92. Desire for predictive testing for Alzheimer's disease and impact on advance care planning: a cross-sectional study..  Alzheimer's research & therapy.  8:-. 2016
93. Beta-Blocker Use in U.S. Nursing Home Residents After Myocardial Infarction: A National Study..  Journal of the American Geriatrics Society.  65:754-762. 2016
94. Perception of primary care physicians on the impact of comprehensive geriatric assessment: what is the next step?.  Israel journal of health policy research.  -. 2016
95. Trends in Drug Utilization, Glycemic Control, and Rates of Severe Hypoglycemia, 2006-2013..  Diabetes care.  40:468-475. 2016
96. Changes in Medication Use After Dementia Diagnosis in an Observational Cohort of Individuals with Diabetes Mellitus..  Journal of the American Geriatrics Society.  65:77-82. 2016
97. Polypharmacy-Time to Get Beyond Numbers..  JAMA internal medicine.  176:482-3. 2016
98. Dextromethorphan-Quinidine for Agitation in Alzheimer Disease..  JAMA.  315:-. 2016
99. Use of Renally Inappropriate Medications in Older Veterans: A National Study..  Journal of the American Geriatrics Society.  63:2290-7. 2015
100. How to Use the American Geriatrics Society 2015 Beers Criteria-A Guide for Patients, Clinicians, Health Systems, and Payors..  Journal of the American Geriatrics Society.  63:e1-e7. 2015
101. Changing Patterns of Glucose-Lowering Medication Use in VA Nursing Home Residents With Diabetes, 2005 to 2011..  Journal of the American Medical Directors Association.  16:898.e9-14. 2015
102. Weight Loss Associated with Cholinesterase Inhibitors in Individuals with Dementia in a National Healthcare System..  Journal of the American Geriatrics Society.  63:1512-8. 2015
103. The Course of Functional Impairment in Older Homeless Adults: Disabled on the Street..  JAMA internal medicine.  175:1237-9. 2015
104. Health Outcomes of Obtaining Housing Among Older Homeless Adults..  American journal of public health.  105:1482-8. 2015
105. Response to Einhorn and colleagues..  Journal of the American Geriatrics Society.  63:1047-8. 2015
106. Case 38-2014: A man with sore throat, hoarseness, fatigue, and dyspnea..  The New England journal of medicine.  372:981-2. 2015
107. Potential overtreatment of diabetes mellitus in older adults with tight glycemic control..  JAMA internal medicine.  175:356-62. 2015
108. Police on the front line of community geriatric health care: challenges and opportunities..  Journal of the American Geriatrics Society.  62:2191-8. 2014
109. Use of opioids and other analgesics by older adults in the United States, 1999-2010..  Pain medicine (Malden, Mass.).  16:319-27. 2014
110. Risk of thiazide-induced metabolic adverse events in older adults..  Journal of the American Geriatrics Society.  62:1039-45. 2014
111. Blood culture use in the emergency department in patients hospitalized for community-acquired pneumonia..  JAMA internal medicine.  174:803-6. 2014
112. Blood culture use in the emergency department in patients hospitalized with respiratory symptoms due to a nonpneumonia illness..  Journal of hospital medicine.  9:521-4. 2014
113. Changing chronic medications in hospitalized patients--bridging the inpatient-outpatient divide..  Journal of hospital medicine.  9:332-3. 2014
114. Identification of risk factors for elevated transaminases in methotrexate users through an electronic health record..  Arthritis care & research.  66:1159-66. 2014
115. Patterns of chronic co-morbid medical conditions in older residents of U.S. nursing homes: differences between the sexes and across the agespan..  The journal of nutrition, health & aging.  18:429-36. 2014
116. Polypharmacy, drug-drug interactions, and potentially inappropriate medications in older adults with human immunodeficiency virus infection..  Journal of the American Geriatrics Society.  62:447-53. 2014
117. Prescribing quality in older veterans: a multifocal approach..  Journal of general internal medicine.  29:1379-86. 2014
118. Characteristics of emergency department visits by older versus younger homeless adults in the United States..  American journal of public health.  103:1046-51. 2013
119. Cumulative changes in the use of long-term medications: a measure of prescribing complexity..  JAMA internal medicine.  173:1546-7. 2013
120. Long-term cognitive and functional effects of potentially inappropriate medications in older women..  The journals of gerontology. Series A, Biological sciences and medical sciences.  69:423-9. 2013
121. Managing chronic disease in hospitalized patients..  JAMA internal medicine.  173:1857-8. 2013
122. Polypharmacy and the management of the older cancer patient..  Annals of oncology : official journal of the European Society for Medical Oncology.  24 Suppl 7:vii36-40. 2013
123. Reaching out to patients to identify adverse drug reactions and nonadherence: necessary but not sufficient..  JAMA internal medicine.  173:375-94. 2013
124. Reasons for not prescribing guideline-recommended medications to adults with heart failure..  Medical care.  51:901-7. 2013
125. Ten-year trajectory of potentially inappropriate medications in very old women: importance of cognitive status..  Journal of the American Geriatrics Society.  61:258-63. 2013
126. The 'worthy' patient: rethinking the 'hidden curriculum' in medical education..  Anthropology & medicine.  20:13-23. 2013
127. Preliminary competencies for comparative effectiveness research..  Clinical and translational science.  5:476-9. 2012
128. Influence of patient age and comorbid burden on clinician attitudes toward heart failure guidelines..  The American journal of geriatric pharmacotherapy.  10:211-8. 2012
129. A clinically guided approach for improving performance measurement for hypertension..  Medical care.  50:399-405. 2012
130. Age and sex variation in prevalence of chronic medical conditions in older residents of U.S. nursing homes..  Journal of the American Geriatrics Society.  60:756-64. 2012
131. Elder care as "frustrating" and "boring": understanding the persistence of negative attitudes toward older patients among physicians-in-training..  Journal of aging studies.  26:476-83. 2012
132. Geographic variation in outpatient antibiotic prescribing among older adults..  Archives of internal medicine.  172:1465-71. 2012
133. Industry support of CME--are we at the tipping point?.  The New England journal of medicine.  366:1069-71. 2012
134. Patterns of multimorbidity in elderly veterans..  Journal of the American Geriatrics Society.  60:1872-80. 2012
135. Regional differences in prescribing quality among elder veterans and the impact of rural residence..  The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association.  29:172-9. 2012
136. Inappropriate medication use in older adults undergoing surgery: a national study..  Journal of the American Geriatrics Society.  59:2139-44. 2011
137. Beyond the prescription: medication monitoring and adverse drug events in older adults..  Journal of the American Geriatrics Society.  59:1513-20. 2011
138. Conducting high-value secondary dataset analysis: an introductory guide and resources..  Journal of general internal medicine.  26:920-9. 2011
139. Age and receipt of guideline-recommended medications for heart failure: a nationwide study of veterans..  Journal of general internal medicine.  26:1152-9. 2011
140. Beers criteria as a proxy for inappropriate prescribing of other medications among older adults..  The Annals of pharmacotherapy.  45:1363-70. 2011
141. Clinician attitudes about commercial support of continuing medical education: results of a detailed survey..  Archives of internal medicine.  171:840-6. 2011
142. Confined to ignorance: the absence of prisoner information from nationally representative health data sets..  Journal of general internal medicine.  27:160-6. 2011
143. Do geriatric conditions increase risk of adverse drug reactions in ambulatory elders? Results from the VA GEM Drug Study..  The journals of gerontology. Series A, Biological sciences and medical sciences.  66:444-51. 2011
144. Geriatric conditions, medication use, and risk of adverse drug events in a predominantly male, older veteran population..  Journal of the American Geriatrics Society.  59:615-21. 2011
145. Using patients to promote evidence-based prescribing: comment on "Communicating uncertainties about prescription drugs to the public"..  Archives of internal medicine.  171:1468-9. 2011
146. Volunteering, driving status, and mortality in U.S. retirees..  Journal of the American Geriatrics Society.  59:274-80. 2011
147. A taxonomy of reasons for not prescribing guideline-recommended medications for patients with heart failure..  The American journal of geriatric pharmacotherapy.  8:583-94. 2010
148. Choice of initial antiepileptic drug for older veterans: possible pharmacokinetic drug interactions with existing medications..  Journal of the American Geriatrics Society.  58:465-71. 2010
149. Commercial influence and learner-perceived bias in continuing medical education..  Academic medicine : journal of the Association of American Medical Colleges.  85:74-9. 2010
150. Coronary risk assessment by point-based vs. equation-based Framingham models: significant implications for clinical care..  Journal of general internal medicine.  25:1145-51. 2010
151. Drug detailing in academic medical centers: regulating for the right reasons, with the right evidence, at the right time..  The American journal of bioethics : AJOB.  10:21-3. 2010
152. Managing medications in clinically complex elders: "There's got to be a happy medium"..  JAMA.  304:1592-601. 2010
153. Suicide-related behaviors in older patients with new anti-epileptic drug use: data from the VA hospital system..  BMC medicine.  -. 2010
154. When tight blood pressure control is not for everyone: a new model for performance measurement in hypertension..  Joint Commission journal on quality and patient safety.  36:164-72. 2010
155. Medication prescribing practices for older prisoners in the Texas prison system..  American journal of public health.  100:756-61. 2009
156. Agreement between drugs-to-avoid criteria and expert assessments of problematic prescribing..  Archives of internal medicine.  169:1326-32. 2009
157. Physician use of brand versus generic drug names in 1993-1994 and 2003-2004..  The Annals of pharmacotherapy.  43:459-68. 2009
158. The Neurontin legacy--marketing through misinformation and manipulation..  The New England journal of medicine.  360:103-6. 2009
159. Variation in outpatient antibiotic prescribing in the United States..  The American journal of managed care.  15:861-8. 2009
160. Interventions to reduce unnecessary antibiotic prescribing: a systematic review and quantitative analysis..  Medical care.  46:847-62. 2008
161. Age affects outcomes in chronic kidney disease..  Journal of the American Society of Nephrology : JASN.  18:2758-65. 2007
162. Attitudes of preclinical and clinical medical students toward interactions with the pharmaceutical industry..  Academic medicine : journal of the Association of American Medical Colleges.  82:94-9. 2007
163. Characteristics and impact of drug detailing for gabapentin..  PLoS medicine.  4:-. 2007
164. Conflicts and concordance between measures of medication prescribing quality..  Medical care.  45:95-9. 2007
165. Evolution of medication use in Jerusalem elders: Results from the Jerusalem Longitudinal Study..  Drugs & aging.  24:133-45. 2007
166. Is continuing medical education a drug-promotion tool?: YES..  Canadian family physician Medecin de famille canadien.  53:1650-7. 2007
167. Number of medical conditions and quality of care..  The New England journal of medicine.  357:1350-1; author reply 1351. 2007
168. Polypharmacy and the balance of medication benefits and risks..  The American journal of geriatric pharmacotherapy.  5:314-6. 2007
169. Rebuttal: Is CME a drug-promotion tool?: YES..  Canadian family physician Medecin de famille canadien.  53:1877, 1878-9. 2007
170. What's in a name? Use of brand versus generic drug names in United States outpatient practice..  Journal of general internal medicine.  22:645-8. 2007
171. Age and rising rates of cyclooxygenase-2 inhibitor use. Results from a national survey..  Journal of general internal medicine.  21:245-50. 2006
172. Mortality risk stratification in chronic kidney disease: one size for all ages?.  Journal of the American Society of Nephrology : JASN.  17:846-53. 2006
173. Improving antibiotic selection: a systematic review and quantitative analysis of quality improvement strategies..  Medical care.  44:617-28. 2006
174. Narrative review: the promotion of gabapentin: an analysis of internal industry documents..  Annals of internal medicine.  145:284-93. 2006
175. Polypharmacy and prescribing quality in older people..  Journal of the American Geriatrics Society.  54:1516-23. 2006
176. Fluoroquinolone prescribing in the United States: 1995 to 2002..  The American journal of medicine.  118:259-68. 2005
177. Interactions between pharmaceutical representatives and doctors in training. A thematic review..  Journal of general internal medicine.  20:777-86. 2005
178. Quality of ambulatory care for women and men in the Veterans Affairs Health Care System..  Journal of general internal medicine.  20:762-5. 2005
179. Clinician awareness of adherence to hypertension guidelines..  The American journal of medicine.  117:747-54. 2004
180. Office evaluation and treatment of elderly patients with acute bronchitis..  Journal of the American Geriatrics Society.  52:875-9. 2004
181. Changing use of antibiotics in community-based outpatient practice, 1991-1999..  Annals of internal medicine.  138:525-33. 2003
182. Donepezil for nursing home patients with dementia: a reinterpretation of the evidence..  Journal of the American Geriatrics Society.  51:132; author reply 132-3. 2003
183. Predictors of broad-spectrum antibiotic prescribing for acute respiratory tract infections in adult primary care..  JAMA.  289:719-25. 2003
184. Finding the target: getting started with quality of care and health services research..  Quality management in health care.  10:19-24. 2002
185. The costs of making practice more cost-effective..  JAMA.  287:1648; author reply 1649-50. 2002
186. Molecular and conventional epidemiology of Mycobacterium tuberculosis in Botswana: a population-based prospective study of 301 pulmonary tuberculosis patients..  Journal of clinical microbiology.  39:1042-7. 2001
187. Of principles and pens: attitudes and practices of medicine housestaff toward pharmaceutical industry promotions..  The American journal of medicine.  110:551-7. 2001
188. Self-restriction of medications due to cost in seniors without prescription coverage..  Journal of general internal medicine.  16:793-9. 2001
189. MSJAMA: gifts to physicians in the consumer marketing era..  JAMA.  284:-. 2000
190. Clarithromycin-associated visual hallucinations in a patient with chronic renal failure on continuous ambulatory peritoneal dialysis..  American journal of kidney diseases : the official journal of the National Kidney Foundation.  27:143-6. 1996